Benzinga's Top Downgrades

Loading...
Loading...
Analysts at Piper Jaffray downgraded
Mirati Therapeutics, Inc. MRTX
from Overweight to Neutral. The target price for Mirati Therapeutics has been lowered from $50 to $45. Mirati Therapeutics shares closed at $44.34 on Wednesday. Analysts at Macquarie downgraded
StarzSTRZA
from undefined to Neutral. Starz shares closed at $40.44 on Wednesday. Analysts at UBS downgraded
Natural Resource Partners LPNRP
from Neutral to Sell. The target price for Natural Resources is set to $2.50. Natural Resources shares closed at $2.97 on Wednesday. BB&T Capital downgraded
Accuride CorporationACW
to Hold. Accuride shares closed at $3.29 on Wednesday.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...